Refractory disease, new horizons and patient–physician relationships
Glode L, Petrylak D. Refractory disease, new horizons and patient–physician relationships. Prostate Cancer And Prostatic Diseases 1999, 2: 19-20. PMID: 12496852, DOI: 10.1038/sj.pcan.4500272.Peer-Reviewed Original ResearchMore cost-effective careRole of chemotherapyDisease-free intervalPhase III trialsUse of PSACost-effective careProstate cancer cellsPatient-physician relationshipAdvanced diseasePain controlIII trialsRefractory diseaseNumerous new targetsFree intervalProstate cancerTreatment endpointSurrogate endpointsBiologic understandingCancer cellsDisease targetsEndpointNew targetsGrowth factor interactionsChemotherapyDisease